ArticleBMC infectious diseases2025
Rare early hematogenous disseminated tuberculosis inducing hemophagocytic syndrome in conflict treatment.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article presents a case of an acute onset in a middle-aged male who exhibited persistent high fever (temperature > 40 °C), delirium, and respiratory distress. Initial chest CT only suggested "bilateral pneumonia," and empirical anti-infection treatment proved ineffective. The patient subsequently developed pancytopenia, splenomegaly, and markedly elevated ferritin levels (848.90 μg/L). Bone marrow aspiration demonstrated hemophagocytic activity and granulomatous lesions. A positive TB-PCR, confirmed the diagnosis of early hematogenous disseminated tuberculosis complicated by the hemophagocytic syndrome (HLH). The patient's condition gradually improved Following, individualized anti-tuberculosis therapy and immunosuppressive treatment. The uniqueness of this case lies in two main aspects: (1) early imaging did not show typical miliary nodules, which could have led to misdiagnosis as common pneumonia; (2) the dissemination of tuberculosis and onset of HLH occurred almost simultaneously, creating a therapeutic dilemma. Although tuberculosis complicated by HLH is rare, it poses significant danger. The cornerstone of treatment is effective control of the tuberculosis infection while simultaneously suppressing the excessive immune response. This case highlights the importance of considering tuberculosis complicated by HLH in patients with recurrent fever and pulmonary infiltrates. Early diagnosis and prompt treatment are crucial for improving prognosis. The article also discusses the underlying pathogenesis, offering valuable insights for clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.